Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2014
06/11/2014CN103857668A Ethynyl derivatives as mglur5 allosteric modulators
06/11/2014CN103857661A 1,2,4-triazolyl-substituted keto-enols
06/11/2014CN103857659A Fused benzoxazepinones as ion channel modulators
06/11/2014CN103848829A Heteroaryl alkyne compounds and application thereof
06/11/2014CN103848822A 1,8-carbazole derivative, preparation method and application thereof in luminescent device
06/11/2014CN103848821A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition
06/11/2014CN103848820A Spiro compound serving as hepatitis C inhibitor and applications thereof in drugs
06/11/2014CN103848819A Spiro compound serving as hepatitis C inhibitor, drug composition and applications of spiro compound and drug composition in drugs
06/11/2014CN103848818A Parallel ring compound serving as hepatitis C inhibitor, drug composition and applications of parallel ring compound and drug composition in drugs
06/11/2014CN103848817A Iodination preparation method for dipeptidyl peptidase inhibitor, chlorination and iodination intermediates of dipeptidyl peptidase inhibitor and preparation methods for intermediates
06/11/2014CN103848816A Reductive amination preparation method for dipeptidyl peptidase inhibitor, and intermediate and preparation method thereof
06/11/2014CN103848814A Substituted indole ketone derivative as tyrosine kinase inhibitor
06/11/2014CN103848810A Bruton's tyrosine kinases inhibitor
06/11/2014CN102947289B Arylethynyl derivatives
06/11/2014CN102596936B Antiviral compounds
06/11/2014CN102256963B Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
06/10/2014US8748603 Crystalline forms of N-[2-[[(2,3-difluorophenyl)methyl]THIO]-6-{[(1R,2S)-2,3-dihydroxy-1-methylpropyl]oxy}-4-pyrimidinyl]-1-azetidinesulfonamide
06/10/2014US8748597 2,4-pyrimidinediamine compounds and their uses
06/10/2014US8748442 sGC stimulators
06/10/2014US8748433 β3 adrenergic receptor agonists
06/10/2014US8748432 Microbiocidal pyrazole derivatives
06/10/2014US8748426 Inhibitors of diacylglycerol acyl transferase
06/10/2014CA2541509C Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
06/05/2014WO2014085528A1 Azaquinazoline carboxamide derivatives
06/05/2014WO2014085490A1 Cxcr7 antagonists
06/05/2014WO2014084778A1 Pyrimidine-2,4-diamine derivatives for treatment of cancer
06/05/2014WO2014084612A1 Novel compound and organic electronic element using same
06/05/2014WO2014082889A1 Novel imidazolines as dual inhibitors of mdm2 and mdmx
06/05/2014WO2014082598A1 Inhibitors of bruton's tyrosine kinase
06/05/2014WO2014082578A1 Heteroaryl alkyne compound and application thereof
06/05/2014WO2014082381A1 Spiro ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
06/05/2014WO2014082380A1 Fused ring compounds as hepatitis c virus inhibitors, pharmaceutical compositions and uses thereof
06/05/2014WO2014082379A1 Spiro ring compound as hepatitis c virus (hcv) inhibitor and uses thereof field of the invention
06/05/2014WO2013106689A8 Hcv ns3 protease inhibitors
06/05/2014US20140155625 Modified Naturally-Derived Colorants For Phase Change Ink Applications
06/05/2014US20140155602 Arlethynyl Derivatives
06/05/2014US20140155447 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents
06/05/2014US20140155421 Substituted pyrimidinyl-pyrroles active as kinase inhibitors
06/05/2014US20140155418 Receptor-Type Kinase Modulators and Methods of Use
06/05/2014US20140155413 TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF
06/05/2014US20140155407 Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases
06/05/2014US20140155402 Bi-heteroaryl compounds as vps34 inhibitors
06/05/2014US20140155386 Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors
06/05/2014US20140155382 Anti-viral compounds
06/05/2014US20140155377 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
06/05/2014US20140155370 Nuclear transport modulators and uses thereof
06/05/2014US20140154772 Inhibitors of human phosphatidylinositol 3-kinase delta
06/04/2014EP2738165A1 Method by means of phase transfer catalysis
06/04/2014EP2736902A1 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors
06/04/2014EP2736901A1 Heterocyclyl pyrimidine analogues as jak inhibitors
06/04/2014EP2736897A1 Substituted picolinic acids and pyrimidine-4-carboxylic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators
06/04/2014EP2736896A1 3-oxo-2,3-dihydro-1h-indazole-4-carboxamide derivatives as parp-1 inhibitors
06/04/2014EP2736887A1 Hydrazide containing nuclear transport modulators and uses thereof
06/04/2014EP2736883A1 Nuclear transport modulators and uses thereof
06/04/2014EP2736514A1 Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors
06/04/2014CN103842340A Nuclear transport modulators and uses thereof
06/04/2014CN103833997A New compound with tozasertib structure as well as preparation method and application thereof
06/04/2014CN103833736A Method for preparing avanafil
06/04/2014CN103833735A Compound for preventing and treating grape downy mildew and composition employing same
06/04/2014CN103833734A Synthesis method of N-aminoethyl terpinene maleimido imidazole derivative
06/04/2014CN103833733A New crystal form of tini-type medicines
06/04/2014CN103833658A Benzotriazole-based piperazine compound as well as preparation method and pharmaceutical composition thereof
06/04/2014CN103833643A Benzimidazolyl-piperazine compound and preparation method and pharmaceutical composition thereof
06/04/2014CN103833642A Application of benzo five-membered nitrogen-containing heterocycle-based piperazine derivative
06/04/2014CN103833544A 11-beta-hydroxysteroid dehydrogenase type i inhibitors
06/04/2014CN102712624B Indole compound and pharmaceutical use thereof
06/04/2014CN102696622B Pesticide composition capable of preventing and controlling plant disease
06/04/2014CN102659685B Process for preparing N-substituted azole derivatives under the catalytic action of metallic iron salt
06/04/2014CN102369187B N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
06/04/2014CN101861313B Phenyl amino pyrimidine compounds and uses thereof
06/04/2014CN101379058B Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
06/03/2014US8742331 Imidazolium-based liquid salts and methods of use thereof
06/03/2014US8742135 Compound amycolamicin, method for producing the same, and use of the same
06/03/2014US8742133 Triazole compounds that modulate HSP90 activity
06/03/2014US8742100 Small molecule inhibitors of isoprenylcysteine carboxyl methyltransferase with potential anticancer activity
06/03/2014US8742097 Triazole compounds I
06/03/2014US8741944 Anti-infective agents against intracellular pathogens
06/03/2014US8741943 Bicyclic compound, production and use thereof
06/03/2014US8741942 Inhibitors of cellular necrosis
06/03/2014US8741914 Antiviral compounds and uses thereof
06/03/2014US8741887 Azetidinyl diamides as monoacylglycerol lipase inhibitors
06/03/2014US8741450 Material for organic electroluminescence devices and organic electroluminescence device using the material
06/03/2014CA2590110C Kinase modulators and method of use
06/03/2014CA2563063C Purification of progesterone receptor modulators
05/2014
05/30/2014WO2014081697A2 Anthelmintic compounds and compositions and method of using thereof
05/30/2014WO2014081689A1 Compounds useful as inhibitors of indoleamine 2,3-dioxygenase
05/30/2014WO2014081388A1 Dopants for solid-state dye-sensitive solar cells
05/30/2014WO2014081206A1 Novel organic electroluminescence compounds and organic electroluminescence device containing the same
05/30/2014WO2014081134A1 Novel compound and organic electroluminescent element comprising same
05/30/2014WO2014079806A1 Pyrimidine compounds for treating hairloss
05/30/2014WO2014079803A1 Bicyclosubstituted pyrazole compounds for treating hairloss
05/30/2014WO2014079155A1 Use of benzo five-membered nitrogen heterocyclic piperazine or piperidine derivatives
05/30/2014WO2014079154A1 Benzo five-membered nitrogen heterocyclic piperidine or piperazine derivatives and preparation methods and pharmaceutical compositions thereof
05/30/2014WO2014055972A3 A new chemical entity useful for treating various diseases
05/30/2014WO2014043252A3 Hydroxypyridinone-,hydroxypyrimidinone-and hydroxypyridazinone drivatives and their therapeutic application
05/29/2014US20140148463 Pyridazinone derivatives
05/29/2014US20140148462 Indanyloxydihydrobenzofuranylacetic acids
05/29/2014US20140148459 Matrix metalloproteinase inhibitors
05/29/2014US20140148448 Inhibitors of c-fms kinase
05/29/2014US20140148443 Novel Imidazolines as dual inhibitors of MDM2 and MDMX
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 626